511 related articles for article (PubMed ID: 20439741)
1. Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth.
Murray BW; Guo C; Piraino J; Westwick JK; Zhang C; Lamerdin J; Dagostino E; Knighton D; Loi CM; Zager M; Kraynov E; Popoff I; Christensen JG; Martinez R; Kephart SE; Marakovits J; Karlicek S; Bergqvist S; Smeal T
Proc Natl Acad Sci U S A; 2010 May; 107(20):9446-51. PubMed ID: 20439741
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of neuroblastoma proliferation by PF-3758309, a small-molecule inhibitor that targets p21-activated kinase 4.
Li Z; Li X; Xu L; Tao Y; Yang C; Chen X; Fang F; Wu Y; Ding X; Zhao H; Li M; Qian G; Xu Y; Ren J; Du W; Wang J; Lu J; Hu S; Pan J
Oncol Rep; 2017 Nov; 38(5):2705-2716. PubMed ID: 29048629
[TBL] [Abstract][Full Text] [Related]
3. Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma.
Dasgupta A; Sierra L; Tsang SV; Kurenbekova L; Patel T; Rajapakse K; Shuck RL; Rainusso N; Landesman Y; Unger T; Coarfa C; Yustein JT
Cancer Res; 2021 Jan; 81(1):199-212. PubMed ID: 33168646
[TBL] [Abstract][Full Text] [Related]
4. Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer.
Zhao CC; Zhan MN; Liu WT; Jiao Y; Zhang YY; Lei Y; Zhang TT; Zhang CJ; Du YY; Gu KS; Wei W
Cancer Lett; 2020 Nov; 493():120-127. PubMed ID: 32829006
[TBL] [Abstract][Full Text] [Related]
5. p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways.
Yun CY; You ST; Kim JH; Chung JH; Han SB; Shin EY; Kim EG
J Invest Dermatol; 2015 May; 135(5):1385-1394. PubMed ID: 25560280
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP-dependent protein kinase A and EPAC mediate VIP and secretin stimulation of PAK4 and activation of Na
Ramos-Alvarez I; Lee L; Jensen RT
Am J Physiol Gastrointest Liver Physiol; 2019 Feb; 316(2):G263-G277. PubMed ID: 30520694
[TBL] [Abstract][Full Text] [Related]
7. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
[TBL] [Abstract][Full Text] [Related]
8. LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells.
Zhang J; Wang J; Guo Q; Wang Y; Zhou Y; Peng H; Cheng M; Zhao D; Li F
Cancer Lett; 2012 Apr; 317(1):24-32. PubMed ID: 22085492
[TBL] [Abstract][Full Text] [Related]
9. p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma.
Qasim SL; Sierra L; Shuck R; Kurenbekova L; Patel TD; Rajapakshe K; Wulff J; Nakahata K; Kim HR; Landesman Y; Unger TJ; Coarfa C; Yustein JT
Oncogene; 2021 Feb; 40(6):1176-1190. PubMed ID: 33414491
[TBL] [Abstract][Full Text] [Related]
10. The Cdc42 Effector Kinase PAK4 Localizes to Cell-Cell Junctions and Contributes to Establishing Cell Polarity.
Selamat W; Tay PL; Baskaran Y; Manser E
PLoS One; 2015; 10(6):e0129634. PubMed ID: 26068882
[TBL] [Abstract][Full Text] [Related]
11. PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion.
Wells CM; Whale AD; Parsons M; Masters JR; Jones GE
J Cell Sci; 2010 May; 123(Pt 10):1663-73. PubMed ID: 20406887
[TBL] [Abstract][Full Text] [Related]
12. Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance.
Khan HY; Ge J; Nagasaka M; Aboukameel A; Mpilla G; Muqbil I; Szlaczky M; Chaker M; Baloglu E; Landesman Y; Mohammad RM; Azmi AS; Sukari A
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905765
[TBL] [Abstract][Full Text] [Related]
13. Repositioning Potential of PAK4 to Osteoclastic Bone Resorption.
Choi SW; Yeon JT; Ryu BJ; Kim KJ; Moon SH; Lee H; Lee MS; Lee SY; Heo JC; Park SJ; Kim SH
J Bone Miner Res; 2015 Aug; 30(8):1494-507. PubMed ID: 25640698
[TBL] [Abstract][Full Text] [Related]
14. P21-activated kinase 4 in pancreatic acinar cells is activated by numerous gastrointestinal hormones/neurotransmitters and growth factors by novel signaling, and its activation stimulates secretory/growth cascades.
Ramos-Alvarez I; Jensen RT
Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G302-G317. PubMed ID: 29672153
[TBL] [Abstract][Full Text] [Related]
15. Discovery and the structural basis of a novel p21-activated kinase 4 inhibitor.
Ryu BJ; Kim S; Min B; Kim KY; Lee JS; Park WJ; Lee H; Kim SH; Park S
Cancer Lett; 2014 Jul; 349(1):45-50. PubMed ID: 24704155
[TBL] [Abstract][Full Text] [Related]
16. p21-activated kinase 1 activity is required for histone H3 Ser
Zhang N; Li X; Liu X; Cao Y; Chen D; Liu X; Wang Q; Du J; Weng J; Ma W
Reprod Fertil Dev; 2017 Jul; 29(7):1287-1296. PubMed ID: 27166635
[TBL] [Abstract][Full Text] [Related]
17. Substrate and inhibitor specificity of the type II p21-activated kinase, PAK6.
Gao J; Ha BH; Lou HJ; Morse EM; Zhang R; Calderwood DA; Turk BE; Boggon TJ
PLoS One; 2013; 8(10):e77818. PubMed ID: 24204982
[TBL] [Abstract][Full Text] [Related]
18. PAK4 Regulates Actin and Microtubule Dynamics during Meiotic Maturation in Mouse Oocyte.
He YT; Yang LL; Luo SM; Shen W; Yin S; Sun QY
Int J Biol Sci; 2019; 15(11):2408-2418. PubMed ID: 31595158
[TBL] [Abstract][Full Text] [Related]
19. Group II p21-activated kinase, PAK4, is needed for activation of focal adhesion kinases, MAPK, GSK3, and β-catenin in rat pancreatic acinar cells.
Ramos-Álvarez I; Lee L; Jensen RT
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G490-G503. PubMed ID: 31984786
[TBL] [Abstract][Full Text] [Related]
20. PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma.
Chung EY; Mai Y; Shah UA; Wei Y; Ishida E; Kataoka K; Ren X; Pradhan K; Bartholdy B; Wei X; Zou Y; Zhang J; Ogawa S; Steidl U; Zang X; Verma A; Janakiram M; Ye BH
Clin Cancer Res; 2019 Jun; 25(12):3589-3601. PubMed ID: 30862694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
